Close

Teva Pharma (TEVA) PT Lowered to $19 at RBC Capital May 3, 2019 06:41AM
4 Things To Look For In Teva Pharma's (TEVA) Report - RBC Mar 27, 2019 07:07AM
Teva Pharma (TEVA) PT Lowered to $20 at RBC Capital Feb 14, 2019 06:50AM
Teva Pharma (TEVA) PT Raised to $22 at RBC Capital Nov 2, 2018 07:26AM
Perrigo plans to separate prescription pharma business Aug 9, 2018 01:04AM
View Older Stories

Jul 31, 2018 07:00AM Teva Pharma (TEVA) PT Raised to $19 at RBC Capital
May 16, 2018 09:20AM Pre-Open Movers 05/16: (BOOT) (ABAX) (M) Higher; (VSTM) (SRAX) (ABR) Lower (more...)
Mar 26, 2018 07:32AM Teva Pharma (TEVA) PT Lowered to $16 at RBC Capital After Cutting Out-Year Estimates
Feb 9, 2018 06:09AM RBC Capital Upgrades Teva Pharma (TEVA) to Sector Perform
Jan 22, 2018 09:29AM Pre-Open Movers 01/22: (BIVV) (JUNO) (ARRY) Higher; (SANM) (TEVA) (TWTR) Lower (more...)
Nov 3, 2017 07:00AM Teva Pharma (TEVA): A Price Below $8 Is Real - RBC
Oct 30, 2017 06:12AM Teva Pharma (TEVA): Cutting PT To $13 On Ongoing Copaxone Pressures - RBC
Sep 18, 2017 06:02AM Teva Pharma (TEVA): Good Announcements But Back-Drop Unchanged, Cutting PT - RBC
Aug 4, 2017 05:54AM RBC Capital Double Downgrades Teva Pharma (TEVA) to Underperform
Jul 17, 2017 06:22AM Teva Pharma (TEVA): Cutting EPS Ahead Of Quarterly Results - RBC
May 15, 2017 06:13AM Teva Pharma (TEVA): Cutting PT After Sector Revisit - RBC
Mar 1, 2017 10:21AM EpiPen maker Mylan forecasts strong 2017; shares jump
Feb 21, 2017 06:06AM Teva Pharma (TEVA): Copaxone Delay A Positive - RBC
Feb 14, 2017 08:47AM RBC Capital Reiterates Outperform Rating and $42 PT on Teva Pharmaceuticals (TEVA) Following 4Q Results
Feb 6, 2017 05:47PM Teva CEO exits in ongoing crisis of confidence at drugmaker
Jan 9, 2017 07:25AM Teva Pharma (TEVA): Street is Too High, Cutting PT - RBC
Nov 14, 2016 07:13AM Teva Pharma (TEVA): Cutting PT "Well Below" Consensus - RBC
Nov 4, 2016 10:27AM Notable Analyst Rating Changes 11/4: (ACHN) (MMC) (HCP) Upgraded; (AXL) (BRO) (WFM) Downgraded
Oct 17, 2016 03:05PM Notable 52-Week Highs and Lows 10/17: (CTRV) (IGT) (TCK) High; (TEVA) (OPB) (ANF) Low
Sep 20, 2016 10:32AM Allergan pays top dollar for 'stepping stones' from neurology to dermatology
Jul 18, 2016 09:17PM Teva Announces Pricing of $15 Billion of Senior Notes in Connection with Pending Acquisition of Actavis Generics
Jul 18, 2016 06:56AM Teva Pharma (TEVA): Setting Up For a Rebound - RBC
Jul 12, 2016 06:35AM Teva Pharma (TEVA): Estimates Fall On Actavis - RBC
Jun 21, 2016 09:53AM Notable Mergers and Acquisitions 6/21: (IPXL) (OSIS)/(ASEI) (TCEHY) (PHG)
Jun 21, 2016 09:52AM Notable Mergers and Acquisitions 6/21: (IPXL) (OSIS)/(ASEI) (TCEHY) (PHG)
Jun 21, 2016 07:05AM Impax Laboratories (IPXL) to Acquire Generics Portfolio from Teva, Allergan; Updates FY16 Outlook
Jun 10, 2016 12:51PM TREANDA Ruling Positive for Eagle Pharma (EGRX) and Teva (TEVA); Removes Huge Uncertainty for EGRX - RBC
May 4, 2016 10:49AM Notable Analyst Rating Changes 5/4: (DG) (FDX) (PLT) Upgraded; (KBH) (MOH) (RLYP) Downgraded
Jan 4, 2016 06:37AM Teva Pharma (TEVA) Underwriters Exercise Overallotment Option in Latest Offering
Jan 3, 2016 02:30AM Teva Announces Exercise of Underwriters’ Over-Allotment Option
Dec 8, 2015 12:16PM Teva Announces Closing of Public Offerings of American Depositary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Actavis Generics
Dec 4, 2015 11:28AM Notable Analyst Rating Changes 12/4: (TEVA) (HBI) (HPP) Upgraded; (M)( GPRO) (KSU) Downgraded
Dec 2, 2015 10:35PM Teva Announces Pricing of Public Offerings of American Depositary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Actavis Generics
Nov 30, 2015 06:54AM Teva Pharma (TEVA) Announces ~$6.75B ADS, Conv. Preferred Offering
Nov 30, 2015 06:54AM Teva Announces Proposed Public Offerings of American Depositary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Actavis Generics
Jul 31, 2015 02:00PM Teva Pharma (TEVA) Secures $33.75B Financing Commitment Relating to Pending Acquisition of Allergan's Generic Business
Jul 31, 2015 01:22PM Teva Secures $33.75 Billion Financing Commitment
Apr 16, 2015 03:06PM Vivus (VVUS) Defends Qsymia IP from Another Generic Giant, RBC Capital Comments
Mar 23, 2015 02:30PM Notable 52-Week Highs and Lows 3/23: (PFE) (TEVA) (DRI) High; (MEIP) (SONS) (YOKU) Low
Mar 18, 2015 10:00AM Notable Mergers and Acquisitions 3/18: (TEVA)/(RXDX) (MSCC)/(VTSS) (MGLN)
Mar 16, 2015 06:53AM RBC Comments on Amgen (AMGN) Repatha Data
Jan 26, 2015 10:47AM Notable Analyst Rating Changes 1/26: (BBBY) (GRMN) (FNFG) Upgraded; (HCP) (STT) (LYB) Downgraded
Nov 3, 2014 08:09AM RBC Capital Upgrades Teva Pharma (TEVA) to Outperform
Apr 16, 2014 10:38AM Notable Analyst Rating Changes 04/16: (SFUN) (TWTR) (YELP) Upgraded; (INTC) (UNH) (GDP) Downgraded
Jan 6, 2014 05:13PM RBC Capital Starts Teva Pharma (TEVA) at Sector Perform
Oct 24, 2011 10:47AM Notable Analyst Rating Changes 10/24: (BHP) (XL) (USU) Upgraded; (WEN) (IFF) (TEVA) Downgraded
Aug 18, 2011 11:19AM Notable Analyst Rating Changes 08/18: (SINA) (UDR) (BIIB) Upgraded; (NTAP) (GT) (IR) Downgraded
Aug 1, 2011 03:08PM Notable 52-Week Highs and Lows of the Day 08/01: (MPEL) (JAZZ) (CROX) High; (SUNH) (TEVA) (HCA) Low
Apr 19, 2011 10:44AM Notable Analyst Rating Changes 04/19: (ZION) (NAV) (RBN) Upgraded; (GS) (ABAT) (CRU) Downgraded
Mar 13, 2009 10:16AM David Moenning's Daily State of the Markets: 3/13
View Older Stories